Showing results (111-120 of 141) with videos related to
Sort By:
Pageof 15
Cell Reports|May 14, 2020
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV ChallengeBarbara K Felber, Zhongyan Lu, Xintao Hu, et al.Immunity|August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in MiceDorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.Nature Medicine|December 16, 2018
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.Biorxiv : the Preprint Server for Biology|June 21, 2024
HIV-1 neutralizing antibodies in SHIV-infected macaques recapitulate structurally divergent modes of human V2 apex recognition with a single D geneRyan S Roark, Rumi Habib, Jason Gorman, et al.Nature Medicine|March 20, 2018
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.Cell Reports. Medicine|April 12, 2023
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertionsTom G Caniels, Max Medina-Ramírez, Jinsong Zhang, et al.Science Translational Medicine|March 17, 2017
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptideS Munir Alam, Baptiste Aussedat, Yusuf Vohra, et al.JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.Biorxiv : the Preprint Server for Biology|December 22, 2025
An integrated workflow for structural virology with a 100 keV electron microscopeRasangi Pathirage, Moumita Dutta, Ruth J Parsons, et al.The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.Pageof 15